Xuemei Hou

Dr. Xuemei Hou

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2017 in Marine Drugs
Verified
Journal Article
Open access
PDF file
TSTing Shi
Ting Shi
JQJun Qi
Jun Qi
Chang-Lun ShaoChang-Lun Shao
Chang-Lun Shao
Dong-Lin ZhaoDong-Lin Zhao
Dong-Lin Zhao
XHXuemei Hou
Xuemei Hou
Chang-Yun WangChang-Yun Wang
Chang-Yun Wang
Three new diphenyl ether derivatives—phomaethers A–C (1–3) and five known compounds—including a diphenyl ether analog, 2,3′-dihydroxy-4-methoxy-5′,6-dimethyl diphenyl ether (4); and four isocoumarin derivatives, diaportinol (5), desmethyldiaportinol (6), citreoisocoumarinol (7), and citreoisocoumarin (8)—were isolated from a gorgonian-derived fungus Phoma sp. (TA07-1). Their structures were elucidated by extensive spectroscopic investigation. The absolute configurations of 1 and 2 were determined by acid hydrolysis reactions. It was the first report to discover the diphenyl glycoside derivatives from coral-derived fungi. Compounds 1, 3, and 4 showed selective strong antibacterial activity against five pathogenic bacteria with the minimum inhibiting concentration (MIC) values and minimum bactericidal concentration (MBC) values between 0.156 and 10.0 μM.

22 November 2017 in Marine Drugs
Verified
Journal Article
Open access
PDF file
XHXuemei Hou
Xuemei Hou
YZyahui zhang
yahui zhang
YHYang Hai
Yang Hai
ZJZheng Ji-yong
Zheng Ji-yong
Yu-Cheng GuYu-Cheng Gu
Yu-Cheng Gu
Chang-Lun ShaoChang-Lun Shao
Chang-Lun Shao
A new centrosymmetric cyclohexapeptide, aspersymmetide A (1), together with a known peptide, asperphenamate (2), was isolated from the fungus Aspergillus versicolor isolated from a gorgonian coral Carijoa sp., collected from the South China Sea. The chemical structure of 1 was elucidated by analyzing its NMR spectroscopy and MS spectrometry data, and the absolute configurations of the amino acids of 1 were determined by Marfey’s method and UPLC-MS analysis of the hydrolysate. Aspersymmetide A (1) represents the first example of marine-derived centrosymmetric cyclohexapeptide. Moreover, 1 exhibited weak cytotoxicity against NCI-H292 and A431 cell lines at the concentration of 10 μM.

20 June 2025 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JWJiaWang Wang
JiaWang Wang
HHHuan Hu
Huan Hu
QWQingQing Wang
QingQing Wang
TZTianZhu Zhu
TianZhu Zhu
XRXiaoHan Ren
XiaoHan Ren
XYXiaoling Yu
Xiaoling Yu
Acinetobacter baumannii is a notable opportunistic pathogen responsible for severe hospital-acquired infections, with multidrug-resistant strains posing significant treatment challenges. Phage therapy, which employs bacteriophages as natural bacterial antagonists, has gained renewed attention as a promising solution to combat antibiotic-resistant infections. In this study, we isolated and characterized a novel virulent phage, vB_AbaS_qsb1, which specifically lyses A.baumannii. Phylogenetic and genomic analyses indicate that vB_AbaS_qsb1 is the founding member of a previously unreported genus, which we propose to name Acinibactriovirus, with Acinibactriovirus lysinus as the type species. vB_AbaS_qsb1 demonstrated robust stability across diverse temperature and pH ranges, a short latent period, and no known virulence or antibiotic resistance genes within its 54,713 bp dsDNA genome. Safety assessments showed that high-dose vB_AbaS_qsb1 induced no adverse effects in mice, with histopathology confirming its safety profile. Therapeutic experiments further indicated that vB_AbaS_qsb1 provided at least 50% protection against A.baumannii-induced pneumonia, significantly reducing bacterial loads and inflammation markers, while maintaining high phage titers in lung tissue.This study introduces vB_AbaS_qsb1 as a promising candidate for phage therapy against A.baumannii, offering both innovative insights and a valuable framework for future isolation, genomic characterization, and efficacy evaluation of phages targeting antibiotic-resistant bacteria.

9 March 2016 in Marine Drugs
Verified
Journal Article
Open access
PDF file
WXWei-Feng Xu
Wei-Feng Xu
XHXuemei Hou
Xuemei Hou
KYKai-Lin Yang
Kai-Lin Yang
FCFei Cao
Fei Cao
RYRuiyun Yang
Ruiyun Yang
Chang-Lun ShaoChang-Lun Shao
Chang-Lun Shao
One new hydroanthraquinone dimer with a rare C-9–C-7′ linkage, nigrodiquinone A (1), and four known anthraquinone monomers 2–5, were isolated from a fungus Nigrospora sp. obtained from the zoanthid Palythoa haddoni collected in the South China Sea. The structure of 1 was established through extensive NMR spectroscopy, and the absolute configuration was elucidated by comparing computed electronic circular dichroism (ECD) and optical rotations (OR) with experimental results. All the compounds were evaluated for antiviral activity, and 1 was also evaluated for antibacterial activity. Compound 4 displayed mild antiviral activity against coxsackie virus (Cox-B3) with the IC50 value of 93.7 μM, and 5 showed an IC50 value of 74.0 μM against respiratory syncytial virus (RSV).

20 January 2026 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
HHHuan Hu
Huan Hu
LWLiang Wang
Liang Wang
LCLi-Qun Chen
Li-Qun Chen
HLHai Lin
Hai Lin
LHLan-Ting Huang
Lan-Ting Huang
XHXuemei Hou
Xuemei Hou
Large language models (LLMs) have emerged as promising tools in the healthcare sector. However, their reliability in the critical task of identifying risky drug combinations remains unvalidated. Here, we systematically evaluated the potential of LLMs for drug combination alerting under the guidance of the CoMed framework through four aspects: (1) the baseline performance of native LLMs, (2) the contribution of external knowledge grounding via Retrieval-Augmented Generation (RAG), (3) the impact of expert-guided reasoning using context engineering, and (4) the utility of a multiagent architecture for comprehensive and interpretable risk analysis. Notably, by integrating RAG and the context engineering strategy, Qwen2.5-Max-CoT achieved outstanding performance (F1 = 0.971, AUC = 0.982), demonstrating expert-level balance between precision and recall. Furthermore, a case study on aspirin-warfarin validated CoMed's ability to generate accurate assessments in a structured and traceable HTML report. This study demonstrates that enhanced LLMs can reliably and transparently support drug combination risk alerting and clinical decision.

4 March 2026 in Foods
Verified
Journal Article
Open access
PDF file
YZYuanhui Zhang
Yuanhui Zhang
NSNengpai Shi
Nengpai Shi
CYChenjie Yang
Chenjie Yang
BWBinbin Wu
Binbin Wu
KZKexin Zhang
Kexin Zhang
XLXiangyang Lin
Xiangyang Lin
The grinding of Tremella fuciformis is a critical step for its value-added processing and the efficient utilization of its functional components, significantly impacting product quality and process adaptability. This study investigated ultrafine grinding (UFG) as a mechano-physical strategy to improve product quality, systematically analyzing its impact on physical properties (particle size, powder characteristics, color), extraction efficiency, chemical composition, and rheological behavior compared to conventional grinding (CG). The results revealed that UFG treatment induced an extensive disruption of the matrix, reducing particle size by 91.8% (D90 = 18.18 μm) and significantly increasing specific surface area. Notably, this physical modification directly translated into enhanced processing performance. UFG powder exhibited reduced powder flowability, superior solubility and improved color brightness. This structural degradation proved beneficial for extraction, unlocking a substantially higher yield (60.98–66.48%). Concurrently, the aqueous extracts of UFG powder exhibited more fluid-like rheological characteristics. This study confirms the potential of UFG as an effective pretreatment for the intensive processing of T. fuciformis and indicates its promising application in functional food development and the extraction of bioactive components.